FDA Drug Recalls

Recalls / Class I

Class ID-0611-2025

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

DermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08

Affected lot / code info
Lot #: 40187.2, Exp. Date 2/2026

Why it was recalled

Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.

Recalling firm

Firm
DermaRite Industries, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
7777 W Side Ave, N/A, North Bergen, New Jersey 07047-6436

Distribution

Quantity
249 bottles
Distribution pattern
Nationwide within the USA

Timeline

Recall initiated
2025-07-17
FDA classified
2025-09-02
Posted by FDA
2025-09-10
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0611-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.